Patentability in healthcare, biotechnology and chemistry: Open recorded webinar

Experimental data: impact on patentability in medical applications

Section

Questions asked by the audience

Objectives

Agenda

Experimental data and sufficiency of disclosure/inventive step

Background

Practical case

Q1: Use of prior art in support of description

Conclusion

Clinical trials and novelty/inventive step

Background

Publication requirements for clinical trial data

Practical case

Q1: Closest prior art
Q2: Broad use claim and post-published evidence

Conclusion

Elsie Cielen, BE, examiner, Team 2nd Medical Use, EPO The Hague. PhD in organic chemistry from the Catholic University of Leuven. Joined the EPO in 1999. Passed the EQE in 2012. Works in the field of second medical applications in search and examination. Examiner in an Opposition & Central Formalities directorate. As an expert in Patent Procedures Management, co-drafter of the EPC and PCT-EPO Guidelines.

Britta Kley, DE, lawyer, Patent Law, EPO Munich. Studied law at the University of Trier and the University of East Anglia. Doctor of Laws. Worked as a litigator for an international law firm. Joined the EPO in 2004 and Directorate Patent Law in 2012.


	Download presentation

back to main page